AquaBounty posts $3.5m loss in first half, says 'no scientific reason' why FDA shouldn't give GE salmon the green light
AquaBounty Technologies - which is hoping to become the first company to introduce a genetically engineered (GE) animal to the human food supply - posted net losses of $3.5m in the six months to June 30, up from a loss of $2.1m in the first half of 2013.